Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 239

The DOI matches its Crossref record.

Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma

Open access
Merchant, Thomas E., Bendel, Anne E., Sabin, Noah D., Burger, Peter C., Shaw, Dennis W., Chang, Eric, Wu, Shengjie, Zhou, Tianni, Eisenstat, David D., Foreman, Nicholas K., Fuller, Christine E., Anderson, Edwina Templeton, Hukin, Juliette, Lau, Ching C., Pollack, Ian F., Laningham, Fred H., Lustig, Robert H., Armstrong, Floyd D., Handler, Michael H., Williams-Hughes, Chris, Kessel, Sandra, Kocak, Mehmet, Ellison, David W., Ramaswamy, Vijay · 2019 · Journal of Clinical Oncology

Abstract

PURPOSE: The Children’s Oncology Group trial ACNS0121 estimated event-free survival (EFS) and overall survival for children with intracranial ependymoma treated with surgery, radiation therapy, and—selectively—with chemotherapy. Treatment was administered according to tumor location, histologic grade, and extent of resection. The impacts of histologic grade, focal copy number gain on chromosome 1q, and DNA methylation profiles were studied for those undergoing surgery and immediate postoperative conformal radiation therapy (CRT). METHODS: ACNS0121 included 356 newly diagnosed patients (ages 1 to 21 years). Patients with classic supratentorial ependymoma were observed after gross total resection (GTR). Those undergoing subtotal resection received chemotherapy, second surgery, and CRT. The remaining patients received immediate postoperative CRT after near-total resection or GTR. CRT was administered with a 1.0-cm clinical target volume margin. The cumulative total dose was 59.4 Gy, except for patients who underwent GTR and were younger than age 18 months (who received 54 Gy). Patients were enrolled between October 2003 and September 2007 and were observed for 5 years. Supratentorial tumors were evaluated for RELA fusion; infratentorial tumors, for chromosome 1q gain. Classification of posterior fossa groups A and B was made by methylation profiles. RESULTS: The 5-year EFS rates were 61.4% (95% CI, 34.5% to 89.6%), 37.2% (95% CI, 24.8% to 49.6%), and 68.5% (95% CI, 62.8% to 74.2%) for observation, subtotal resection, and near-total resection/GTR groups given immediate postoperative CRT, respectively. The 5-year EFS rates differed significantly by tumor grade ( P = .0044) but not by age, location, RELA fusion status, or posterior fossa A/posterior fossa B grouping. EFS was higher for patients with infratentorial tumors without 1q gain than with 1q gain (82.8% [95% CI, 74.4% to 91.2%] v 47.4% [95% CI, 26.0% to 68.8%]; P = .0013). CONCLUSION: The EFS for patients with ependymoma younger than 3 years of age who received immediate postoperative CRT and for older patients is similar. Irradiation should remain the mainstay of care for most subtypes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.18.01765

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 239

Metadata

Authors
Merchant, T. E., Bendel, A. E., Sabin, N. D., Burger, P. C., Shaw, D. W., Chang, E., Wu, S., Zhou, T., Eisenstat, D. D., Foreman, N. K., Fuller, C. E., Anderson, E. T., Hukin, J., Lau, C. C., Pollack, I. F., Laningham, F. H., Lustig, R. H., Armstrong, F. D., Handler, M. H., Williams-Hughes, C., Kessel, S., Kocak, M., Ellison, D. W., & Ramaswamy, V.
Venue
Journal of Clinical Oncology
Published
2019-04-20
Volume
37
Issue
12
Pages
974-983
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2918069808
Cited by
239
References
0
FWCI
13.43
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma. https://app.cochat.ai/papers/10.1200/jco.18.01765
The paper
Merchant, T. E., Bendel, A. E., Sabin, N. D., Burger, P. C., Shaw, D. W., Chang, E., Wu, S., Zhou, T., Eisenstat, D. D., Foreman, N. K., Fuller, C. E., Anderson, E. T., Hukin, J., Lau, C. C., Pollack, I. F., Laningham, F. H., Lustig, R. H., Armstrong, F. D., Handler, M. H., . . . Ramaswamy, V. (2019). Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma. Journal of Clinical Oncology. https://doi.org/10.1200/jco.18.01765

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.